通过双价位1-位2连接体对抗胰岛素受体的结构基础
Amber Vogel1, Alan Blakely1, Yuankun Dao2
1Department of Biochemistry, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT, USA.
bioRxiv : the preprint server for biology
|September 2, 2025
概括
通过了解胰岛素受体 (IR) 抗剂S961和Ins-AC-S2如何结合IR,可以促进先天性高胰岛素症 (HI) 的治疗. 它的结合体结构决定了它是否作为激动剂或抗剂,为未来的药物开发提供了信息.
科学领域:
- 生物化学
- 结构生物学
- 药理学
背景情况:
- 先天性高胰岛素症 (HI) 是一种罕见的遗传性疾病,导致胰岛素的过度产生.
- 胰岛素受体 (IR) 抗剂是HI的潜在治疗剂.
- 像S961和Ins-AC-S2这样的可以向IR的胰岛素结合部位 (部位1和部位2).
研究的目的:
- 使用冷电子显微镜 (cryo-EM) 阐明S961和Ins-AC-S2的红外对抗性的结构基础.
- 了解双价联体中结合模块的顺序如何影响红外激动或抗活性.
- 确定S961和Ins-AC-S2与IR的结合机制的结构差异.
主要方法:
- 电子显微镜 (cryo-EM) 用于确定与S961和Ins-AC-S2结合的IR结构.
- 配体与受体相互作用的比较结构分析.
主要成果:
- 低温-EM结构显示S961和Ins-AC-S2结合了非活性的红外形状,解释了它们的对抗作用.
- 1位点和2位点的结合模块的顺序决定了双价联体是否作为IR激动剂或抗剂.
- 观察到不同的结合机制:S961取代了αCT,而Ins-AC-S2则参与了它,揭示了新的结合接口.
结论:
- 对红外抗体结合机制的结构见解为开发新型HI疗法提供了基础.
- 了解配体-受体相互作用对于设计向的IR调节器至关重要.
- αCT和新型结合接口的差异性参与突显了S961和Ins-AC-S2结合之间的关键差异.
相关概念视频
Insulin: The Receptor and Signaling Pathways
1.5K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.5K
Ligand Binding and Linkage
4.9K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.9K
The Two-State Receptor Model
2.4K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.4K
Ligand Binding Sites
13.1K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
13.1K
Glucagon-like Receptor Agonists
416
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
416
Insulin: Biosynthesis, Chemistry, and Preparation
518
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
518


